Fractyl Health, Inc. Common Stock
GUTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | -0.17 | -0.67 | -0.52 |
| FCF Yield | -75.02% | -7.06% | -7.57% | -5.48% |
| EV / EBITDA | -0.91 | -13.15 | -17.76 | -22.64 |
| Quality | ||||
| ROIC | -100.29% | -75.03% | -89.96% | -38.64% |
| Gross Margin | 46.24% | 35.83% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.95 | 0.56 | 1.00 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -55.82% | 6.73% | -38.15% | -7.85% |
| Safety | ||||
| Net Debt / EBITDA | 0.05 | -1.05 | -5.26 | -5.76 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -25.61 |
| Efficiency | ||||
| Inventory Turnover | 0.68 | 1.05 | 0.00 | 0.00 |
| Cash Conversion Cycle | -23,119.10 | -2,208.41 | -791.37 | -523.74 |